Bongsup Cho obtained a Ph.D. in Medicinal Chemistry from the University of Illinois Medical Center in 1985. After conducting his postdoctoral work at both the University of Chicago and the Food and Drug Administration, he joined the University of Rhode Island’s College of Pharmacy in 1991, where he is currently Professor of Biomedical and Pharmaceutical Sciences and Associate Dean for Research and Graduate Education. Cho is a chemical/structural biologist, a medicinal chemist, and an expert on chemical carcinogenesis. His current research is focused on the structure-function-relationships of DNA damage and the molecular mechanisms underlying the protein-DNA interactions involved in DNA repair and replication. Cho’s research has been supported primarily by grants from the National Institutes of Health (NIH) and American Cancer Society. Cho has published extensively on areas of cancer and molecular toxicology and presented numerous abstracts/proceedings at national and international conferences. Cho has mentored a large group of undergraduate and graduate students, postdoctoral fellows, and has actively served as a grant reviewer for various federal and private funding agencies, including the NIH and National Science Foundation (NSF). He has served as a permanent member for the NIH Cancer Etiology Study Section and various programs grants. Cho is a member of the American Chemical Society, American Association for Cancer Research, and the American Association for Advancement of Science. He currently serves as the Program Coordinator of the Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) program, a multi-milliondollar NIH infrastructure grant. Cho teaches the chemical and molecular aspects of cancer and neuro drugs as well as advanced medicinal chemistry and drug metabolism.

Structure-function-relationships of DNA damage and the molecular mechanisms underlying the protein-DNA interactions involved in DNA repair and replication, cancer and molecular toxicology, chemical and molecular aspects of cancer and neuro drugs.